Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| DarioHealth Corp.DRIO · Entity 7024 | President and CCO | September 11, 2025 | September 15, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
DarioHealth Corp.
Report date September 11, 2025 · Filed September 15, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 34,750 |
Reported balance
After 2025-09-11 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-09-11 · Grant · Acquired 30,000 · Balance 34,750 F1: The restricted share award shall vest on the last day of the second-year anniversary after the grant date. F2: The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025. |
Filing footnotes · ownership attribution and instrument terms
F1: The restricted share award shall vest on the last day of the second-year anniversary after the grant date.
F2: The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 11, 2025 Filed Sep 15, 2025 18:04 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantCommon Stock | 30,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001104659-25-090098 · tm2526001-10_4seq1.xml · nonDerivative · entry 1 Nelson Steven Charles · CIK 0002025906 · President and CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 34,750 F1 · date: The restricted share award shall vest on the last day of the second-year anniversary after the grant date. F2 · balance_after: The number of shares beneficially owned reflects the 20-for-1 reverse stock split effected on August 28, 2025. Read SEC document |
| August 27, 2025 Filed Aug 27, 2025 16:30 UTC | DarioHealth Corp. DRIO · Entity 7024 | PurchaseCommon Stock | 40,000 | $0.53 | $21,200.00 |
DisclosureSEC source: 0001104659-25-084035 · tm2524544-1_4seq1.xml · nonDerivative · entry 1 Nelson Steven Charles · CIK 0002025906 · President and CCO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 95,000 Read SEC document |
| November 12, 2024 Filed Nov 14, 2024 16:15 UTC | DarioHealth Corp. DRIO · Entity 7024 | PurchaseCommon Stock | 5,000 | $0.91 | $4,546.00 |
DisclosureSEC source: 0001104659-24-118926 · tm2428408-1_4seq1.xml · nonDerivative · entry 1 Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 55,000 Read SEC document |
| September 11, 2024 Filed Sep 12, 2024 16:37 UTC | DarioHealth Corp. DRIO · Entity 7024 | PurchaseCommon Stock | 5,000 | $0.80 | $4,022.50 |
DisclosureSEC source: 0001104659-24-099353 · tm2423915-1_4seq1.xml · nonDerivative · entry 2 Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Read SEC document |
| September 10, 2024 Filed Sep 12, 2024 16:37 UTC | DarioHealth Corp. DRIO · Entity 7024 | PurchaseCommon Stock | 5,000 | $0.84 | $4,221.00 |
DisclosureSEC source: 0001104659-24-099353 · tm2423915-1_4seq1.xml · nonDerivative · entry 1 Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,000 Read SEC document |
| September 09, 2024 Filed Sep 10, 2024 06:00 UTC | DarioHealth Corp. DRIO · Entity 7024 | PurchaseCommon Stock | 5,000 | $0.80 | $4,000.00 |
DisclosureSEC source: 0001104659-24-098312 · tm2423624-1_4seq1.xml · nonDerivative · entry 3 Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 40,000 Read SEC document |
| September 06, 2024 Filed Sep 10, 2024 06:00 UTC | DarioHealth Corp. DRIO · Entity 7024 | PurchaseCommon Stock | 5,000 | $0.84 | $4,200.50 |
DisclosureSEC source: 0001104659-24-098312 · tm2423624-1_4seq1.xml · nonDerivative · entry 2 Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,000 Read SEC document |
| September 05, 2024 Filed Sep 10, 2024 06:00 UTC | DarioHealth Corp. DRIO · Entity 7024 | PurchaseCommon Stock | 5,000 | $0.82 | $4,091.00 |
DisclosureSEC source: 0001104659-24-098312 · tm2423624-1_4seq1.xml · nonDerivative · entry 1 Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 30,000 Read SEC document |
| August 23, 2024 Filed Aug 23, 2024 16:05 UTC | DarioHealth Corp. DRIO · Entity 7024 | PurchaseCommon Stock | 5,000 | $0.95 | $4,749.50 |
DisclosureSEC source: 0001104659-24-092420 · tm2422584-2_4seq1.xml · nonDerivative · entry 3 Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,000 Read SEC document |
| August 22, 2024 Filed Aug 23, 2024 16:05 UTC | DarioHealth Corp. DRIO · Entity 7024 | PurchaseCommon Stock | 5,000 | $0.95 | $4,725.00 |
DisclosureSEC source: 0001104659-24-092420 · tm2422584-2_4seq1.xml · nonDerivative · entry 2 Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,000 Read SEC document |
| August 21, 2024 Filed Aug 23, 2024 16:05 UTC | DarioHealth Corp. DRIO · Entity 7024 | PurchaseCommon Stock | 5,000 | $0.93 | $4,672.50 |
DisclosureSEC source: 0001104659-24-092420 · tm2422584-2_4seq1.xml · nonDerivative · entry 1 Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,000 Read SEC document |
| August 20, 2024 Filed Aug 20, 2024 16:01 UTC | DarioHealth Corp. DRIO · Entity 7024 | PurchaseCommon Stock | 5,000 | $0.94 | $4,684.50 |
DisclosureSEC source: 0001104659-24-091267 · tm2422157-2_4seq1.xml · nonDerivative · entry 2 Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,000 Read SEC document |
| August 19, 2024 Filed Aug 20, 2024 16:01 UTC | DarioHealth Corp. DRIO · Entity 7024 | PurchaseCommon Stock | 5,000 | $0.92 | $4,598.50 |
DisclosureSEC source: 0001104659-24-091267 · tm2422157-2_4seq1.xml · nonDerivative · entry 1 Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,000 Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 16:02 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantStock Option (right to buy) · Derivative | 1,200,000 | $0.00 Strike: $1.35 | $0.00 |
DisclosureSEC source: 0001104659-24-069618 · tm2416654-2_4seq1.xml · derivative · entry 3 Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,350,000 Underlying: Common Stock · 1,350,000 shares Expires 2034-06-05 F3 · derivative.exercise_date: The options vest as follows: 400,000 shares begin to vest over three years in 12 equal quarterly amounts upon achieving certain milestones relating to the achievement of revenues (on a U.S. generally accepted account principles basis) for each of the years ending December 31, 2025, December 31, 2026 and December 31, 2027. F3 · derivative.expiration_date: The options vest as follows: 400,000 shares begin to vest over three years in 12 equal quarterly amounts upon achieving certain milestones relating to the achievement of revenues (on a U.S. generally accepted account principles basis) for each of the years ending December 31, 2025, December 31, 2026 and December 31, 2027. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 16:02 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantStock Option (right to buy) · Derivative | 400,000 | $0.00 Strike: $1.35 | $0.00 |
DisclosureSEC source: 0001104659-24-069618 · tm2416654-2_4seq1.xml · derivative · entry 2 Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 400,000 Underlying: Common Stock · 400,000 shares Expires 2034-06-05 F2 · derivative.exercise_date: The options vest immediately upon achieving certain milestones relating to the achievement of revenues (on a U.S. generally accepted account principles basis) for the year ending December 31, 2024. F2 · derivative.expiration_date: The options vest immediately upon achieving certain milestones relating to the achievement of revenues (on a U.S. generally accepted account principles basis) for the year ending December 31, 2024. Read SEC document |
| June 05, 2024 Filed Jun 7, 2024 16:02 UTC | DarioHealth Corp. DRIO · Entity 7024 | GrantStock Option (right to buy) · Derivative | 500,000 | $0.00 Strike: $1.35 | $0.00 |
DisclosureSEC source: 0001104659-24-069618 · tm2416654-2_4seq1.xml · derivative · entry 1 Nelson Steven Charles · CIK 0002025906 · Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 500,000 Underlying: Common Stock · 500,000 shares Expires 2034-06-05 F1 · derivative.exercise_date: The options vest as follows: 500,00 shares vest over three years in three equal yearly amounts, subject to the Reporting Person's continued services to the Issuer on the applicable vesting date. F1 · derivative.expiration_date: The options vest as follows: 500,00 shares vest over three years in three equal yearly amounts, subject to the Reporting Person's continued services to the Issuer on the applicable vesting date. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.